Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

MicroRNAs in the development of resistance to antiseizure drugs and their potential as biomarkers in pharmacoresistant epilepsy

J. Bohosova, J. Vajcner, P. Jabandziev, H. Oslejskova, O. Slaby, S. Aulicka

. 2021 ; 62 (11) : 2573-2588. [pub] 20210905

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019643

Although many new antiseizure drugs have been developed in the past decade, approximately 30%-40% of patients remain pharmacoresistant. There are no clinical tools or guidelines for predicting therapeutic response in individual patients, leaving them no choice other than to try all antiseizure drugs available as they suffer debilitating seizures with no relief. The discovery of predictive biomarkers and early identification of pharmacoresistant patients is of the highest priority in this group. MicroRNAs (miRNAs), a class of short noncoding RNAs negatively regulating gene expression, have emerged in recent years in epilepsy, following a broader trend of their exploitation as biomarkers of various complex human diseases. We performed a systematic search of the PubMed database for original research articles focused on miRNA expression level profiling in patients with drug-resistant epilepsy or drug-resistant precilinical models and cell cultures. In this review, we summarize 17 publications concerning miRNAs as potential new biomarkers of resistance to antiseizure drugs and their potential role in the development of drug resistance or epilepsy. Although numerous knowledge gaps need to be filled and reviewed, and articles share some study design pitfalls, several miRNAs dysregulated in brain tissue and blood serum were identified independently by more than one paper. These results suggest a unique opportunity for disease monitoring and personalized therapeutic management in the future.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019643
003      
CZ-PrNML
005      
20220804135845.0
007      
ta
008      
220720s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/epi.17063 $2 doi
035    __
$a (PubMed)34486106
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bohosova, Julia $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
245    10
$a MicroRNAs in the development of resistance to antiseizure drugs and their potential as biomarkers in pharmacoresistant epilepsy / $c J. Bohosova, J. Vajcner, P. Jabandziev, H. Oslejskova, O. Slaby, S. Aulicka
520    9_
$a Although many new antiseizure drugs have been developed in the past decade, approximately 30%-40% of patients remain pharmacoresistant. There are no clinical tools or guidelines for predicting therapeutic response in individual patients, leaving them no choice other than to try all antiseizure drugs available as they suffer debilitating seizures with no relief. The discovery of predictive biomarkers and early identification of pharmacoresistant patients is of the highest priority in this group. MicroRNAs (miRNAs), a class of short noncoding RNAs negatively regulating gene expression, have emerged in recent years in epilepsy, following a broader trend of their exploitation as biomarkers of various complex human diseases. We performed a systematic search of the PubMed database for original research articles focused on miRNA expression level profiling in patients with drug-resistant epilepsy or drug-resistant precilinical models and cell cultures. In this review, we summarize 17 publications concerning miRNAs as potential new biomarkers of resistance to antiseizure drugs and their potential role in the development of drug resistance or epilepsy. Although numerous knowledge gaps need to be filled and reviewed, and articles share some study design pitfalls, several miRNAs dysregulated in brain tissue and blood serum were identified independently by more than one paper. These results suggest a unique opportunity for disease monitoring and personalized therapeutic management in the future.
650    _2
$a antikonvulziva $x farmakologie $x terapeutické užití $7 D000927
650    _2
$a biologické markery $7 D015415
650    _2
$a léková rezistence $x genetika $7 D004351
650    12
$a refrakterní epilepsie $x farmakoterapie $x genetika $7 D000069279
650    12
$a epilepsie $x farmakoterapie $x genetika $7 D004827
650    _2
$a lidé $7 D006801
650    12
$a mikro RNA $x genetika $7 D035683
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Vajcner, Jiri $u Department of Pediatric Neurology, Brno Epilepsy Center, University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Jabandziev, Petr $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $u Department of Pediatrics, University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Oslejskova, Hana $u Department of Pediatric Neurology, Brno Epilepsy Center, University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Aulicka, Stefania $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $u Department of Pediatric Neurology, Brno Epilepsy Center, University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/000000016421046X
773    0_
$w MED00001567 $t Epilepsia $x 1528-1167 $g Roč. 62, č. 11 (2021), s. 2573-2588
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34486106 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135839 $b ABA008
999    __
$a ok $b bmc $g 1823021 $s 1170886
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 62 $c 11 $d 2573-2588 $e 20210905 $i 1528-1167 $m Epilepsia $n Epilepsia $x MED00001567
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace